FDA Approves HYDROCODONE BITARTRATE AND IBUPROFEN — Aurolife Pharma, LLC

# FDA Approves Generic Hydrocodone Bitartrate and Ibuprofen Combination Aurolife Pharma, LLC has received FDA approval for a generic version of the hydrocodone bitartrate and ibuprofen combination tablet, potentially intensifying competition in the pain management market and putting downward pressure on pricing for this widely-used opioid-NSAID combination therapy. The approval expands treatment options for patients while offering healthcare providers and payers additional cost-effective alternatives to branded formulations.